Research Triangle Park-based Quintiles Transnational has extended its global network of laboratories by entering an agreement to provide central laboratory services for Medca Japan.
Quintiles, whose laboratories are certified by the College of American Pathologists, will have its own staff at the CAP-certified Medca Japan laboratory in Saitama, a city in the Greater Tokyo area. The lab will support clinical trials in Japan.
"Recent changes in legislation are allowing Japanese pharmaceutical companies to extend clinical trials normally conducted in Japan to other countries in Asia, but these companies have had difficulty finding central lab services that are harmonized throughout the region," said Tom Wollman, senior vice president, Quintiles Global Central Laboratories.
"With CAP-certified labs in Beijing, Singapore, Mumbai and now Japan, we can provide well-controlled processes and harmonized testing services throughout the Asia- Pacific region to customers in Japan as well as our multinational customers. This lab, along with all labs in our network, will follow the same standard operating procedures, and data will be available on our QNET database."